High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors

High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors

There are currently no established second- and later-line therapies for postmenopausal women with hormone receptor-positive advanced or metastatic breast cancer. We examined the efficacy of high-dose toremifene (HD-TOR) for this patient group and whether aromatase inhibitor (AI) resistance influence...

Full description

Saved in:
Bibliographic Details
Main Authors: Atsushi Fushimi, Isao Tabei, Azusa Fuke, Tomoyoshi Okamoto, Hiroshi Takeyama
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2020/7156574
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items